Health Care & Life Sciences » Biotechnology | Cidara Therapeutics Inc.

Cidara Therapeutics Inc.

Cidara Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
27.68 M
Public Float
19.06 M
Cidara Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.66
Market Cap
$43.43 M
Shares Outstanding
26.64 M
Public Float
19.54 M

Profile

Address
6310 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.cidara.com
Updated 07/08/2019
Cidara Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of anti-infectives for the treatment of fungal infections. Its portfolio includes CD101 IV, CD101 Topical, and Cloudbreak. The company was founded by Kevin M.

Financials

View All

Jeffrey L. Stein
President, CEO, CFO & Director
Scott M. Rocklage
Chairman